> Real-time Quotes & News

Real-time Quotes

Product
Bid
Ask
High
Low
Previous Close
*The above quotes are for reference only

Real-time News

2026-01-28

The Indonesian Stock Exchange (IBSE) stated that the Financial Services Authority (FSA), the IBS, and the Indonesian Securities Depository and Clearing Corporation (ISDC) will continue consultations with MSCI.

The Indonesian Stock Exchange (IBSE) stated that the Financial Services Authority (FSA), the IBS, and the Indonesian Securities Depository and Clearing Corporation (ISDC) will continue consultations with MSCI.
2026-01-28

Mixue Group (02097.HK) saw its intraday decline widen to 10%.

Mixue Group (02097.HK) saw its intraday decline widen to 10%.
2026-01-28

Indonesian stocks fell 7%, prompting MSCI to suspend index adjustments.

Indonesian stocks fell 7%, prompting MSCI to suspend index adjustments.
2026-01-28

According to The Information, C3.AI is in talks to merge with startup Automation Anywhere. If the deal goes through, Automation Anywhere will acquire C3.AI and subsequently go public.

According to The Information, C3.AI is in talks to merge with startup Automation Anywhere. If the deal goes through, Automation Anywhere will acquire C3.AI and subsequently go public.
2026-01-28

A-share oil and gas sector rallied again, with CNOOC rising more than 5% to a new high, Sinopec Oilfield Service hitting the daily limit, and Tongyuan Petroleum, CNOOC Development, Zhunyou Petroleum, Xinjin Power and PetroChina following suit.

A-share oil and gas sector rallied again, with CNOOC rising more than 5% to a new high, Sinopec Oilfield Service hitting the daily limit, and Tongyuan Petroleum, CNOOC Development, Zhunyou Petroleum, Xinjin Power and PetroChina following suit.
2026-01-28

A-share innovative drug concept stocks saw some activity, with Guang Sheng Tang rising over 12%, followed by gains in Yue Wannianqing, 3SBio, Kaipu Bio, Shutaishan, and Hengrui Medicine.

A-share innovative drug concept stocks saw some activity, with Guang Sheng Tang rising over 12%, followed by gains in Yue Wannianqing, 3SBio, Kaipu Bio, Shutaishan, and Hengrui Medicine.